Connect with us
We’re experimenting with AI-generated content to help deliver information faster and more efficiently.
While we try to keep things accurate, this content is part of an ongoing experiment and may not always be reliable.
Please double-check important details — we’re not responsible for how the information is used.

Diseases and Conditions

Starving Tumors: A New Approach to Making Cancer Treatment Work Better

Pancreatic cancer cells are known for being hard to treat, partly because they change the environment around them to block drugs and immune cells. Scientists discovered that these tumors use a scavenging process—called macropinocytosis—to pull nutrients from nearby tissue and keep growing. By blocking this process in mice, researchers were able to change the tumor’s environment, making it softer, less dense, and easier for immune cells and therapies to reach.

Avatar photo

Published

on

The battle against cancer has long been an uphill struggle. Despite advances in treatment, the disease still claims too many lives. However, scientists have made a groundbreaking discovery that could change the game – starving tumors to make cancer treatment more effective.

Cancer cells and tumors do not exist in isolation. They interact with their surrounding environment, which is composed of immune cells, connective tissue, blood vessels, and proteins and carbohydrates that provide structure and other supportive functions. Pancreatic ductal adenocarcinoma (PDAC) cells, for instance, use a cellular scavenging process called macropinocytosis to grab extra nutrients from the extracellular matrix.

Macropinocytosis affects the area surrounding the tumor, making connective tissue stiffer and preventing immune cells from reaching the tumor. Researchers at the NCI-Designated Cancer Center at Sanford Burnham Prebys published findings in Cancer Cell demonstrating that blocking macropinocytosis reshapes the tumor microenvironment to be less fibrous and allows more access to immune cells.

The researchers observed that nearby fibroblasts, which typically form connective tissue and produce many components of the extracellular matrix captured during macropinocytosis, are coerced to become cancer-associated fibroblasts (CAF) that help tumors grow. These CAFs provide metabolites and growth signals, as well as helping in other ways.

When macropinocytosis was blocked, CAFs experienced metabolic stress due to deprivation of glutamine, one of the 20 amino acids used to build proteins throughout the body. PDAC relies heavily on glutamine, so CAFs in the pancreatic cancer tumor microenvironment are regularly starved of it.

Preventing macropinocytosis led to a change to a different subtype of CAF marked by the expression of genes that promote inflammation. This altered CAF population had fewer myofibroblasts, which make the tumor microenvironment stiff and fibrotic, and more inflammatory CAFs, which allow for greater access to immune cells.

The research team found significant changes in the tumor neighborhood resulting from preventing macropinocytosis in CAFs. There were fewer deposits of collagen that make the tumor microenvironment stiff or fibrotic, more access for CD4+ and CD8+ T cells to infiltrate the tumor, and vascular expansion, which promotes drug delivery.

The investigators then tested the effects of combining a treatment to block macropinocytosis with immunotherapy and chemotherapy. They found that this combination significantly suppressed tumor metastasis and prolonged mouse survival.

These findings have significant implications for cancer patients, particularly those with PDAC, which is the third leading cause of cancer deaths despite accounting for only three percent of cases. The scientists will continue to explore how to prevent tumors from scavenging energy to reshape the tumor microenvironment into one that makes cancer treatments more effective.

As lead author Yijuan Zhang, PhD, said, “We believe this is a very promising strategy to pursue for developing combination therapies for cancer patients.”

Diabetes

Unlocking the Secret to a Calorie-Burning Furnace: Scientists Discover Key Amino Acid for Weight Loss

Cutting calories doesn’t just slim you down—it also reduces cysteine, an amino acid that flips fat cells from storage mode to fat-burning mode. Researchers found that lowering cysteine sparks the conversion of white fat into heat-producing brown fat, boosting metabolism and promoting weight loss in both humans and animal models.

Avatar photo

Published

on

The study, published in Nature Metabolism, reveals that consuming fewer calories is not the only way to improve health and lose weight. Researchers have discovered a specific sulfur-containing amino acid called cysteine as a key component in weight loss. When participants restricted their calorie intake, it resulted in reduced levels of cysteine in white fat cells.

The Pennington Biomedical researchers, Dr. Eric Ravussin and Dr. Krisztian Stadler, examined cysteine’s role in metabolism and found that it triggers the transition of white fat cells to brown fat cells. These more active fat cells burn energy to produce heat and maintain body temperature. When researchers restricted cysteine entirely in animal models, it drove high levels of weight loss and increased fat burning and browning of fat cells.

Dr. Stadler stated, “In addition to the dramatic weight loss and increase in fat burning resulting from the removal of cysteine, the amino acid is also central to redox balance and redox pathways in biology.” This suggests future weight management strategies that might not rely exclusively on reducing caloric intake.

The article is based on results from trials involving both human participants and animal models. For the human trials, researchers examined fat tissue samples taken from trial participants who had actively restricted calorie intake over a year. The exploration of these metabolites indicated a reduced level of cysteine.

Dr. Ravussin said, “Reverse translation of a human caloric restriction trial identified a new player in energy metabolism.” Systemic cysteine depletion in mice caused weight loss with increased fat utilization and browning of adipocytes.

The tissue samples came from participants in the CALERIE clinical trial, which recruited healthy young and middle-aged men and women who were instructed to reduce their calorie intake by an average of 14% over two years. With the reduction of cysteine, the participants also experienced subsequent weight loss, improved muscle health, and reduced inflammation.

In the animal models, researchers provided meals with reduced calories. This resulted in a 40% drop in body temperature, but regardless of the cellular stress, the animal models did not exhibit tissue damage, suggesting that protective systems may kick in when cysteine is low.

Dr. John Kirwan, Executive Director of Pennington Biomedical Research Center, stated, “Dr. Ravussin, Dr. Stadler, and their colleagues have made a remarkable discovery showing that cysteine regulates the transition from white to brown fat cells, opening new therapeutic avenues for treating obesity.” I would like to congratulate this research team on uncovering this important metabolic mechanism that could eventually transform how we approach weight management interventions.

Continue Reading

Animals

Nature’s Anti-Aging Hack? Jewel Wasp Larvae Slow Their Biological Clock

Scientists discovered that jewel wasp larvae that undergo a developmental “pause” live longer and age more slowly at the molecular level by nearly 30%. This slowdown is tied to conserved biological pathways, hinting at possible applications for human aging.

Avatar photo

Published

on

The discovery by scientists at the University of Leicester has revealed that jewel wasps can undergo a natural “time-out” as larvae before emerging into adulthood with this surprising advantage. The study, published in PNAS, shows that this pause in development within the wasp dramatically extends lifespan and decelerates the ticking of the so-called “epigenetic clock” that marks molecular aging.

Aging isn’t just about counting birthdays; it’s also a biological process that leaves molecular fingerprints on our DNA. One of the most accurate markers of this process is the epigenetic clock, which tracks chemical changes in DNA, known as methylation, that accumulate with age. The study found that by altering the course of development itself, the jewel wasps could slow down their aging process at a molecular level.

To investigate this phenomenon, a team of researchers exposed jewel wasp mothers to cold and darkness, triggering a hibernation-like state in their babies called diapause. This natural “pause button” extended the offsprings’ adult lifespan by over a third. Even more remarkably, the wasps that had gone through diapause aged 29% more slowly at the molecular level than their counterparts.

“It’s like the wasps who took a break early in life came back with extra time in the bank,” said Evolutionary Biology Professor Eamonn Mallon, senior author on the study. “It shows that aging isn’t set in stone; it can be slowed by the environment, even before adulthood begins.”

The researchers found that this molecular slowdown was linked to changes in key biological pathways that are conserved across species, including those involved in insulin and nutrient sensing. These same pathways are being targeted by anti-aging interventions in humans.

What makes this study novel and surprising is that it demonstrates a long-lasting, environmentally triggered slowdown of aging in a system that’s both simple and relevant to human biology. It offers compelling evidence that early life events can leave lasting marks not just on health but on the pace of biological aging itself.

Understanding how and why aging happens is a major scientific challenge. This study opens up new avenues for research, not just into the biology of wasps, but into the broader question of whether we might one day design interventions to slow aging at its molecular roots. With its genetic tools, measurable aging markers, and clear link between development and lifespan, Nasonia vitripennis is now a rising star in aging research.

“In short, this tiny wasp may hold big answers to how we can press pause on aging,” concluded Professor Mallon. Funding for the study was provided by The Leverhulme Trust and The Biotechnology and Biological Sciences Research Council (BBSRC).

Continue Reading

Animals

“Nature’s Armor: Scientists Uncover Gene Behind Aussie Skinks’ Immunity to Deadly Snake Venom”

Australian skinks have developed a remarkable genetic defense against venomous snake bites by mutating a key muscle receptor, making them resistant to neurotoxins. These tiny but powerful molecular changes mirror those found in cobra-resistant mammals like mongooses and honey badgers. This evolutionary arms race not only shows how adaptable life can be but also offers exciting possibilities for creating new antivenoms and therapies in human medicine.

Avatar photo

Published

on

The article has been rewritten to improve clarity, structure, and style while maintaining the core ideas:

Nature’s Armor: Scientists Uncover Gene Behind Aussie Skinks’ Immunity to Deadly Snake Venom

In a groundbreaking study led by the University of Queensland, scientists have discovered the genetic secret behind Australian skinks’ remarkable ability to withstand deadly snake venom. The research, published in the International Journal of Molecular Sciences, reveals that these small lizards have evolved a molecular armor to protect themselves from the toxic effects of neurotoxins.

Professor Bryan Fry from UQ’s School of the Environment explained that the skinks’ defense mechanism involves tiny changes in a critical muscle receptor called the nicotinic acetylcholine receptor. This receptor is normally targeted by snake venom, which blocks nerve-muscle communication and leads to rapid paralysis and death. However, in a stunning example of evolutionary adaptation, researchers found that skinks independently developed mutations on 25 occasions to block venom from attaching.

“It’s a testament to the massive evolutionary pressure exerted by venomous snakes after their arrival and spread across the Australian continent,” Professor Fry said. “The same mutations evolved in other animals like mongooses, which feed on cobras.”

Researchers confirmed that Australia’s Major Skink (Bellatorias frerei) has developed exactly the same resistance mutation as the honey badger, famous for its immunity to cobra venom.

To validate these findings, scientists conducted functional testing at UQ’s Adaptive Biotoxicology Laboratory. Dr. Uthpala Chandrasekara led the laboratory work and reported that the data was “crystal clear.” The modified receptors simply didn’t respond to toxins, demonstrating their remarkable ability to repel deadly snake venom.

This research has significant implications for biomedical innovation, particularly in the development of novel antivenoms or therapeutic agents. Dr. Chandrasekara emphasized that understanding how nature neutralizes venom can provide valuable clues for designing more effective treatments.

The project involved collaborations with museums across Australia and offers a promising example of interdisciplinary research, bridging the gap between scientific discovery and potential applications.

Continue Reading

Trending